What Calysta makes
Calysta describes itself as a cellular agriculture company that makes protein through a patented fermentation platform using no arable land and no plant or animal inputs. The company was founded in 2012, has its headquarters in Silicon Valley, California, and runs a research and development hub in Teesside in the United Kingdom. Staff in China work alongside joint venture partners.
The core product is FeedKind, a microbial protein for animal nutrition. FeedKind Aqua serves shrimp, salmon and warmwater carnivorous finfish, FeedKind Terra is aimed at early animal nutrition such as post-weaning piglets and chick starter diets, and FeedKind Pet is a vegan protein source for dog and cat diets. FeedKind Net Zero uses renewable energy.
The most recent product is Positive Protein, a microbial protein ingredient for human foods. The website says it will be announced as the company’s first product for people, and a 2022 news item records the appointment of an executive described as marking a move into the food sector. Readers can find background on this category under single-cell protein.
Fermentation process
The process page describes four steps. Gases supplying oxygen, nitrogen, carbon and energy are mixed in a proprietary fermenter, where the company’s microorganisms consume them. The microbial protein is then separated from the liquid, and water and nutrients return to the fermenter. The protein is dried and packaged to customer specifications, and products ship worldwide.
The organism is described as a naturally occurring, non-GMO microorganism. A buyer should ask which species and which carbon source are used, although the sustainability page refers to methanation, which converts captured carbon dioxide back into usable carbon and energy using renewable power. The microbes release carbon dioxide like any aerobic fermentation.
Because the fermentation is aerobic and runs on gases, heat removal and gas transfer drive the engineering. The company calls the fermenter modular and says replication of that design will allow output of more than 100,000 tonnes per year. These are forward-looking statements, and a buyer should separate them from the capacity actually operating when assessing supply security.
Product data and approvals
The FeedKind website states crude protein of 71 percent and crude fat of 9 percent, and calls the material highly digestible, non-GMO and free of animal-derived by-products, ingredients or additives. It reports animal trials in which FeedKind replaced other high-protein ingredients and improved growth rates and feed efficiency, described qualitatively.
For Positive Protein, the company says the protein is purified into a stream of essential amino acids, vitamins and minerals, with the highest digestibility rating among protein ingredients and a natural richness in branched-chain amino acids. No specification sheet appears on the pages reviewed, so amino acid profile, nucleic acid content and digestibility data should be requested directly.
Approvals are listed in general terms. The website says FeedKind is approved in the European Union, United States, China and other countries, and the news list records US FDA GRAS status for aquaculture in February 2023 and Chinese agriculture ministry approval for aquaculture feeds in January 2024. Human food use is a separate question.
Production sites and partners
The FeedKind website names a patented fermenter in Chongqing, China, operated with the partner Calysseo, as the only production site listed. Calysseo is a 50/50 joint venture with Adisseo that sells FeedKind Aqua globally. The company site states that the first plant produces thousands of tonnes a year, and the news list shows groundbreaking in January 2021.
Other partnerships involve pet food. Marsapet co-developed a complete dog food featuring FeedKind Pet, and a news item from March 2025 records its launch. Dr Clauder’s collaborated on an air-dried dog treat. A news entry from August 2024 describes the first major shipment of FeedKind Pet arriving in Europe, which shows the export route for animal nutrition products.
The news list also records a plan with Adisseo for an alternative protein facility in Saudi Arabia, which was in development in November 2022, according to a news item. A buyer should ask for the current status of any planned site, since the pages do not say which plants are running today.
Sustainability claims
The sustainability page gives several figures without a stated method. A FeedKind plant is said to produce 100,000 tonnes of protein a year on about 10 hectares of developed land, compared with roughly 250,000 hectares of arable land for equivalent soy protein. Water savings of nearly 9 million cubic metres are quoted for replacing soy.
FeedKind Aqua in China is stated to produce 20,000 tonnes of protein a year, which the company equates to 100,000 tonnes of wild-caught fish. The process is called circular, and net zero carbon impact is described as a commitment. No life cycle assessment appears, so a buyer needing an environmental claim should request the underlying study.
These comparisons depend on the system boundary, the energy source and the soy reference. Renewable electricity for methanation and gas compression would change the result significantly. Ask for the assessment report, its allocation rules and the electricity mix assumed, and treat the page statements as supplier positioning until an independent review has confirmed them.
What a buyer would check
Define whether the use is feed or food. FeedKind grades are feed ingredients, and each has its own approvals, while Positive Protein is intended for human food and would need a novel food or GRAS route depending on the market. Ask which authorisation covers the grade and the country, and request copies of the notices or decisions.
Request full specifications and lot data. Useful items include crude protein, nucleic acid content, amino acid profile, digestibility, ash, moisture, particle size, heavy metals and microbiological limits. Nucleic acid level matters for food use, since microbial protein carries more RNA than most plant proteins, and sensory properties such as colour and flavour decide inclusion rates in finished products.
Finally, check supply continuity and economics. The company states that its protein is price competitive with existing sources, which should be tested against a written quote. Ask how many fermenters are running, who operates the plant, what stock is held, and how price is set relative to soy or fishmeal indices before committing a formulation.